Latest Breaking News On - Pasithea therapeutics corp - Page 1 : comparemela.com

Pasithea Therapeutics (NASDAQ:KTTA) Stock Price Down 1 8%

Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Free Report) fell 1.8% on Tuesday . The company traded as low as $5.60 and last traded at $5.60. 463 shares were traded during trading, a decline of 94% from the average session volume of 7,761 shares. The stock had previously closed at $5.71. Pasithea Therapeutics Trading Down 1.6 […]

Pasithea therapeutics corpPasithea therapeuticsGet free reportTherapeutics trading downTherapeutics corpPasithea therapeutics daily

Pasithea Therapeutics Announces The First Cohort Has Completed The Initial Dosing In Its Phase 1 Trial Evaluating PAS-004 In RAS, NF1 And RAF Mutated

Pasithea Therapeutics Announces The First Cohort Has Completed The Initial Dosing In Its Phase 1 Trial Evaluating PAS-004 In RAS, NF1 And RAF Mutated
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesTiago reis marquesPasithea therapeutics corpExchange commissionWhile the companyChief executive officerSolid tumorsAmyotrophic lateral sclerosisPrivate securities litigation reform actAnnual reportQuarterly report

Pasithea Therapeutics (NASDAQ:KTTA) Trading Down 0 4%

Pasithea Therapeutics (NASDAQ:KTTA) Trading Down 0 4%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Exchange commissionPasithea therapeutics company profileVanguard group incPasithea therapeutics corpPasithea therapeuticsGet free reportFree reportTherapeutics corpCentral nervous systemPasithea therapeutics daily

Pasithea Therapeutics (NASDAQ:KTTA) Shares Down 2 1%

Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Free Report)’s stock price dropped 2.1% on Wednesday . The stock traded as low as $7.00 and last traded at $7.15. Approximately 1,502 shares traded hands during trading, a decline of 87% from the average daily volume of 11,483 shares. The stock had previously closed at $7.30. Pasithea Therapeutics […]

Pasithea therapeutics corpVanguard group incPasithea therapeutics company profileSecurities exchange commissionPasithea therapeuticsGet free reportFree reportTherapeutics corpCentral nervous systemPasithea therapeutics dailyNasdaq ktta

Pasithea Therapeutics Corp (NASDAQ:KTTA) Sees Large Increase in Short Interest

Pasithea Therapeutics Corp. (NASDAQ:KTTA – Get Free Report) was the target of a large growth in short interest in January. As of January 15th, there was short interest totalling 13,500 shares, a growth of 29.8% from the December 31st total of 10,400 shares. Approximately 0.1% of the shares of the stock are short sold. Based […]

Vanguard group incPasithea therapeutics corpPasithea therapeutics company profilePasithea therapeuticsGet free reportFree reportTherapeutics corpCentral nervous systemPasithea therapeutics dailyNasdaq ktta